KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Depreciation & Amortization (CF): 2018-2024

Historic Depreciation & Amortization (CF) for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $16.0 million.

  • Castle Biosciences' Depreciation & Amortization (CF) rose 7.77% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.8 million, marking a year-over-year increase of 217.86%. This contributed to the annual value of $16.0 million for FY2024, which is 29.74% up from last year.
  • Castle Biosciences' Depreciation & Amortization (CF) amounted to $16.0 million in FY2024, which was up 29.74% from $12.3 million recorded in FY2023.
  • Castle Biosciences' Depreciation & Amortization (CF)'s 5-year high stood at $16.0 million during FY2024, with a 5-year trough of $472,000 in FY2020.
  • For the 3-year period, Castle Biosciences' Depreciation & Amortization (CF) averaged around $13.0 million, with its median value being $12.3 million (2023).
  • Data for Castle Biosciences' Depreciation & Amortization (CF) shows a peak YoY soared of 621.82% (in 2021) over the last 5 years.
  • Castle Biosciences' Depreciation & Amortization (CF) (Yearly) stood at $472,000 in 2020, then surged by 621.82% to $3.4 million in 2021, then skyrocketed by 209.45% to $10.5 million in 2022, then increased by 16.95% to $12.3 million in 2023, then climbed by 29.74% to $16.0 million in 2024.